http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2021, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 13 Apr 2021 06:59:01 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html for the full story. http://www.streetinsider.com/Corporate+News/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html Tue, 13 Apr 2021 06:59:01 -0400 BHC VRX http://www.streetinsider.com/Corporate+News/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html for the full story. http://www.streetinsider.com/Corporate+News/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html Tue, 13 Apr 2021 06:59:01 -0400 BHC VRX http://www.streetinsider.com/FDA/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html for the full story. http://www.streetinsider.com/FDA/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html Tue, 13 Apr 2021 06:59:01 -0400 BHC VRX http://www.streetinsider.com/FDA/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html for the full story. http://www.streetinsider.com/FDA/Bausch+Health+%28BHC%29+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252825.html Tue, 13 Apr 2021 06:59:01 -0400 BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html for the full story. http://www.streetinsider.com/PRNewswire/Bausch+%2B+Lomb+Announces+Statistically+Significant+Topline+Results+From+The+First+Phase+3+Trial+Of+NOV03+%28perfluorohexyloctane%29+In+Dry+Eye+Disease+Associated+With+Meibomian+Gland+Dysfunction/18252810.html Tue, 13 Apr 2021 06:58:00 -0400 A.02252850 A.06822034 A.09642568 A.38083561 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Wed, 24 Feb 2021 06:59:00 -0400 A.02252850 A.06822034 A.07924463 A.08202439 A.09642568 A.23456867 A.30928266 A.33059383 A.33218029 A.60012000 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Wed, 24 Feb 2021 06:59:00 -0400 A.02252850 A.06822034 A.07924463 A.08202439 A.09642568 A.23456867 A.30928266 A.33059383 A.33218029 A.60012000 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Wed, 24 Feb 2021 06:59:00 -0400 A.02252850 A.06822034 A.07924463 A.08202439 A.09642568 A.23456867 A.30928266 A.33059383 A.33218029 A.60012000 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Wed, 24 Feb 2021 06:59:00 -0400 A.02252850 A.06822034 A.07924463 A.08202439 A.09642568 A.23456867 A.30928266 A.33059383 A.33218029 A.60012000 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Wed, 24 Feb 2021 06:59:00 -0400 A.02252850 A.06822034 A.07924463 A.08202439 A.09642568 A.23456867 A.30928266 A.33059383 A.33218029 A.60012000 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Wed, 24 Feb 2021 06:59:00 -0400 A.02252850 A.06822034 A.07924463 A.08202439 A.09642568 A.23456867 A.30928266 A.33059383 A.33218029 A.60012000 BHC BHC VRX http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html for the full story. http://www.streetinsider.com/Press+Releases/Bausch+Health+Companies+Inc.+Announces+Fourth-Quarter+And+Full-Year+2020+Results+And+Provides+2021+Guidance/18022746.html Wed, 24 Feb 2021 06:59:00 -0400 A.02252850 A.06822034 A.07924463 A.08202439 A.09642568 A.23456867 A.30928266 A.33059383 A.33218029 A.60012000 BHC BHC VRX